SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001033427-18-000005
Filing Date
2018-01-08
Accepted
2018-01-08 15:43:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 eaglepharm13g12312017.htm SC 13G 71840
2 eaglepharmex99.htm EX-99 8207
  Complete submission text file 0001033427-18-000005.txt   81617
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88022 | Film No.: 18516338
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST ROAD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

IRS No.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G